Kindred Biosciences reported $15.35M in Loan Capital for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Adma Biologics ADMA:US $ 94.36M 0.49M
Bayer BAYN:GR € 36974M 310M
Eli Lilly And LLY:US $ 15522.4M 785.8M
Idexx Laboratories IDXX:US $ 778.02M 2.05M
JAZZ PHA JAZZ:US $ 6253.65M 241.68M
Kindred Biosciences KIN:US $ 15.35M 1.58M
Minerva Neurosciences NERV:US $ 0M 0M
Novavax NVAX:US $ 323.1M 8.84M
Phibro Animal Health PAHC:US $ 394.01M 11.3M
Zoetis ZTS:US $ 6592M 0M